Clínica Baviera Past Earnings Performance
Past criteria checks 5/6
Clínica Baviera has been growing earnings at an average annual rate of 25.5%, while the Healthcare industry saw earnings growing at 12.2% annually. Revenues have been growing at an average rate of 16.3% per year. Clínica Baviera's return on equity is 39.8%, and it has net margins of 15.8%.
Key information
25.5%
Earnings growth rate
24.1%
EPS growth rate
| Healthcare Industry Growth | 13.4% |
| Revenue growth rate | 16.3% |
| Return on equity | 39.8% |
| Net Margin | 15.8% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Clínica Baviera (BME:CBAV) Might Become A Compounding Machine
Mar 01
Clínica Baviera's (BME:CBAV) Dividend Will Be €0.405
Nov 20Investors Shouldn't Overlook Clínica Baviera's (BME:CBAV) Impressive Returns On Capital
Jan 20These 4 Measures Indicate That Clínica Baviera (BME:CBAV) Is Using Debt Safely
Sep 15Investors Shouldn't Overlook The Favourable Returns On Capital At Clínica Baviera (BME:CBAV)
Apr 12Clínica Baviera (BME:CBAV) Seems To Use Debt Rather Sparingly
Mar 21Clínica Baviera, S.A.'s (BME:CBAV) Stock Is Going Strong: Is the Market Following Fundamentals?
Feb 22Shareholders Of Clínica Baviera (BME:CBAV) Must Be Happy With Their 177% Total Return
Jan 30Here's What To Make Of Clínica Baviera's (BME:CBAV) Returns On Capital
Jan 09
Here's Why We Think Clínica Baviera's (BME:CBAV) Statutory Earnings Might Be Conservative
Dec 19Clínica Baviera (BME:CBAV) Has A Pretty Healthy Balance Sheet
Nov 28Revenue & Expenses BreakdownBeta
How Clínica Baviera makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 227 | 36 | 12 | 0 |
| 30 Sep 23 | 217 | 32 | 0 | 0 |
| 30 Jun 23 | 212 | 31 | 0 | 0 |
| 31 Mar 23 | 204 | 29 | 0 | 0 |
| 31 Dec 22 | 198 | 30 | 12 | 0 |
| 30 Sep 22 | 193 | 30 | 10 | 0 |
| 30 Jun 22 | 189 | 30 | 10 | 0 |
| 31 Mar 22 | 184 | 31 | 10 | 0 |
| 31 Dec 21 | 173 | 27 | 10 | 0 |
| 30 Sep 21 | 165 | 28 | 8 | 0 |
| 30 Jun 21 | 160 | 27 | 8 | 0 |
| 31 Mar 21 | 134 | 20 | 8 | 0 |
| 31 Dec 20 | 123 | 14 | 8 | 0 |
| 30 Sep 20 | 117 | 12 | 9 | 0 |
| 30 Jun 20 | 112 | 9 | 9 | 0 |
| 31 Mar 20 | 124 | 11 | 0 | 0 |
| 31 Dec 19 | 124 | 13 | 9 | 0 |
| 30 Sep 19 | 119 | 12 | 15 | 0 |
| 30 Jun 19 | 115 | 12 | 15 | 0 |
| 31 Mar 19 | 110 | 12 | 15 | 0 |
| 31 Dec 18 | 109 | 12 | 15 | 0 |
| 30 Sep 18 | 107 | 11 | 15 | 0 |
| 30 Jun 18 | 106 | 12 | 15 | 0 |
| 31 Mar 18 | 104 | 11 | 15 | 0 |
| 31 Dec 17 | 100 | 10 | 15 | 0 |
| 30 Sep 17 | 97 | 8 | 13 | 0 |
| 30 Jun 17 | 94 | 8 | 13 | 0 |
| 31 Mar 17 | 92 | 8 | 13 | 0 |
| 31 Dec 16 | 92 | 8 | 13 | 0 |
| 30 Sep 16 | 92 | 9 | 13 | 0 |
| 30 Jun 16 | 91 | 8 | 13 | 0 |
| 31 Mar 16 | 88 | 6 | 13 | 0 |
| 31 Dec 15 | 86 | 5 | 13 | 0 |
| 30 Sep 15 | 84 | 4 | 13 | 0 |
| 30 Jun 15 | 83 | 4 | 13 | 0 |
| 31 Mar 15 | 83 | 3 | 13 | 0 |
| 31 Dec 14 | 83 | 4 | 13 | 0 |
| 30 Sep 14 | 80 | 3 | 12 | 0 |
| 30 Jun 14 | 79 | 3 | 12 | 0 |
| 31 Mar 14 | 80 | 5 | 12 | 0 |
| 31 Dec 13 | 80 | 5 | 12 | 0 |
| 30 Sep 13 | 92 | 0 | 16 | 0 |
| 30 Jun 13 | 80 | 7 | 12 | 0 |
Quality Earnings: CBAV has high quality earnings.
Growing Profit Margin: CBAV's current net profit margins (15.8%) are higher than last year (14.9%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: CBAV's earnings have grown significantly by 25.5% per year over the past 5 years.
Accelerating Growth: CBAV's earnings growth over the past year (21.9%) is below its 5-year average (25.5% per year).
Earnings vs Industry: CBAV earnings growth over the past year (21.9%) exceeded the Healthcare industry 1.3%.
Return on Equity
High ROE: CBAV's Return on Equity (39.8%) is considered high.